Steffen Thomas's Insider Trades & SAST Disclosures
Steffen Thomas's most recent trade in Anavex Life Sciences Corporation was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steffen Thomas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Purchase of securities on an exchange or from another person at price $ 4.52 per share. | 15 May 2024 | 5,000 | 5,000 (0%) | 0% | 4.5 | 22,600 | Common Stock |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges